This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Crucell Holland B.v., Stichting Klinische Farmacologie Groningen. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2008
Title: Rudolf Allert De Boer: Innovator in Cardiac Treatment
Introduction
Rudolf Allert De Boer is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of cardiac failure. His innovative approach has led to the development of a unique patent that addresses a critical health issue.
Latest Patents
Rudolf Allert De Boer holds a patent for the "Use of erythropoietin for the preventive or curative treatment of cardiac failure." This patent outlines the uses of erythropoietin, or a derivative or functional analogue thereof, for the production of a medicament aimed at preventing or curing patients suffering from, or at risk of suffering from, cardiac failure. He has 1 patent to his name.
Career Highlights
Throughout his career, Rudolf has worked with various organizations, including Crucell Holland B.V. and Stichting Klinische Farmacologie Groningen. His work has been instrumental in advancing medical treatments and improving patient outcomes.
Collaborations
Rudolf has collaborated with notable professionals in his field, including Ronald Hendrik Peter Brus and Dirk Jan Van Veldhuisen. These collaborations have further enriched his research and development efforts.
Conclusion
Rudolf Allert De Boer is a distinguished inventor whose work in cardiac treatment has the potential to make a significant impact on patient care. His innovative patent and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile